A majority of U.S. senators and representatives receive campaign funding from pharmaceutical companies — an important part of ...
Meanwhile, the value of five pharmaceutical companies fell in 2017 as Merck & Co, Celgene, GlaxoSmithKline (GSK), Allergan and Shire all saw their market capitalisation decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results